Varian, A Siemens Healthineers Company

This study tests a daily adaptive radiation therapy for muscle-invasive bladder cancer. The goal is to see if this personalized approach reduces diarrhea and other bowel side effects compared to standard radiation. About 110 adults with bladder cancer will participate, and the tr…

This study was designed for people with stage III non-small cell lung cancer who need both chemotherapy and radiation. It compared daily adaptive radiation (which adjusts the beam each session) to standard radiation, hoping to reduce coughing, shortness of breath, and trouble swa…

This study tests a new imaging system called HyperSight that takes clearer, faster 3D scans during radiation therapy for cancer. The goal is to see if these scans are good enough to help doctors plan treatment more accurately. About 40 adults with head and neck, breast, lung, upp…